Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07653282
PHASE1/PHASE2
Effect of GnRH Agonist in FET
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
To evaluate the impact of single dose GnRH agonist administration as luteal phase support on pregnancy outcomes in frozen ICSI cycle
Official title: Single Dose of Gonadotropin Releasing Hormone (GnRH)-Agonist as an Adjuvant Luteal Phase Support in Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) Cycles Prospective Comparative Study
Key Details
Gender
FEMALE
Age Range
20 Years - 39 Years
Study Type
INTERVENTIONAL
Enrollment
122
Start Date
2026-08-01
Completion Date
2028-08-01
Last Updated
2026-06-17
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
GnRH agonist
women undergoing frozen ICSI cycles receiving progesterone + GnRH agonist for luteal phase support.
Locations (1)
Assiut University
Asyut, Muslum, Egypt